Please login to create your UC TechAlerts.
Request a new password for
Required
Find technologies available for licensing from all ten University of California (UC) campuses.
No technologies match these criteria. Schedule UC TechAlerts to receive an email when technologies are published that match this search. Click on the Save Search link above
Network Of Architected Structures For Fluid And Heat Transport
An innovative, nature-inspired system that efficiently captures, transports, and stores fluids while providing passive cooling through controlled fluid dynamics.
Programmable Peptide Nucleic Acid-Based Nanoplatform for Customizable Drug Delivery
Researchers at the University of California, Davis have developed a peptide nucleic acid-based system enabling precise and customizable delivery of antigens, adjuvants, and targeting molecules for improved cancer immunotherapy.
1-(Benzo[1,2-b:4,5-b']Difuran-4-yl)alkyl-2-amines and 1-(2,3,6,7-Tetrahydrobenzo[1,2-b:4,5-b']Difuran-4-yl)butan-2-amines as Serotonin Receptor Modulators for Neurodegenerative Disorders
Researchers at the University of California, Davis have developed novel serotonin receptor modulators designed as mixed 5-HT2A/2C partial agonists that demonstrate promising disease-modifying potential for Parkinson’s Disease with improved safety and efficacy.
Azocino[4,5,6-cd]Indoles, Methods for Preparation and Medical Use Thereof: Simplified Synthetic Access to a New Class of 5-HT Ligands
Researchers at the University of California, Davis have developed a novel class of compounds for modulating serotonin receptors, offering potential treatment for various psychiatric and neurological disorders without inducing hallucinogenic effects.
Proximity-Enhanced NHSF Crosslinker: A Breakthrough Technology for Precise Protein Interaction Mapping and Structural Analysis
Brief description not available
Optimization Of Lead Small Molecule Inhibitors Of Taspase1 For Cancer Therapeutics
GECCO: A Genetic Engineering Method for Introducing Reactive Amino Acids into Proteins
A Covalent Protein Inhibitor For Sars-Cov-2